Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 12:11:668466.
doi: 10.3389/fonc.2021.668466. eCollection 2021.

The Genomic Landscape of Serrated Lesion of the Colorectum: Similarities and Differences With Tubular and Tubulovillous Adenomas

Affiliations

The Genomic Landscape of Serrated Lesion of the Colorectum: Similarities and Differences With Tubular and Tubulovillous Adenomas

Luigi Tornillo et al. Front Oncol. .

Abstract

Serrated lesions of the colorectum are the precursors of 15-30% of colorectal cancers (CRCs). These lesions have a peculiar morphological appearance, and they are more difficult to detect than conventional adenomatous polyps. In this study, we sought to define the genomic landscape of these lesions using high-depth targeted sequencing. Eight sessile serrated lesions without dysplasia (SSL), three sessile serrated lesions with dysplasia (SSL/D), two traditional serrated adenomas (TSA), and three tubular adenomas (TA) were retrieved from the files of the Institute of Pathology of the University Hospital Basel and from the GILAB AG, Allschwil, Switzerland. Samples were microdissected together with the matched normal counterpart, and DNA was extracted for library preparation. Library preparation was performed using the Oncomine Comprehensive Assay targeting 161 common cancer driver genes. Somatic genetic alterations were defined using state-of-the-art bioinformatic analysis. Most SSLs, as well as all SSL/Ds and TSAs, showed the classical BRAF p.V600E mutation. The BRAF-mutant TSAs showed additional alterations in CTNNB1, NF1, TP53, NRAS, PIK3CA, while TA showed a consistently different profile, with mutations in ARID1A (two cases), SMAD4, CDK12, ERBB3, and KRAS. In conclusion, our results provide evidence that SSL/D and TSA are similar in somatic mutations with the BRAF hotspot somatic mutation as a major driver of the disease. On the other hand, TAs show a different constellation of somatic mutations such as ARID1A loss of function.

Keywords: BRAF; DNA sequencing; colorectal cancer; serrated lesions; tubulovillous adenoma.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Histological micrographs (A, C, E, G) and immunohistochemical stain results for MLH1 (B, D, F, H). (A, B) SSL without dysplasia (SSA08T); (C, D) SSL with dysplasia (ID SSA05T); (E, F) TSA (SSA04T); (G, H) TA (SSA15T). Note negativity for MLH1 in SSA05T (D).
Figure 2
Figure 2
Repertoire of somatic genetic alterations in the serrated lesion of the colorectum. Heatmap indicating somatic genetic alterations identified in samples subjected to sequencing. Somatic alterations are color-coded according to the legend. Hotspot mutations are non-synonymous mutations that are in hotspot residues (see Materials and Methods).

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin (2018) 68:394–424. doi: 10.3322/caac.21492 - DOI - PubMed
    1. Kinzler KW, Vogelstein B. Lessons From Hereditary Colorectal Cancer. Cell (1996) 87:159–70. doi: 10.1016/s0092-8674(00)81333-1 - DOI - PubMed
    1. Colussi D, Brandi G, Bazzoli F, Ricciardiello L. Molecular Pathways Involved in Colorectal Cancer: Implications for Disease Behavior and Prevention. Int J Mol Sci (2013) 14:16365–85. doi: 10.3390/ijms140816365 - DOI - PMC - PubMed
    1. IJspeert JEG, Vermeulen L, Meijer GA, Dekker E. Serrated Neoplasia—Role in Colorectal Carcinogenesis and Clinical Implications. Nat Rev Gastroenterol Hepatol (2015) 12:401–9. doi: 10.1038/nrgastro.2015.73 - DOI - PubMed
    1. Bettington M, Walker N, Clouston A, Brown I, Leggett B, Whitehall V. The Serrated Pathway to Colorectal Carcinoma: Current Concepts and Challenges. Histopathology (2013) 62:367–86. doi: 10.1111/his.12055 - DOI - PubMed